We're taking precautions to protect you during the covid-19 pandemic. Prepare for your visit by reading our covid-19 protocols. covid 19 precautions
Khrom Dermatology & Aesthetics
2797 Ocean Pkwy.
3rd Floor, Brooklyn, NY 11235 | Directions
Aesthetics: 855-507-7282
General Dermatology: 718-751-0674

FDA Clears First Topical Form of Minocycline for Acne

Before and after image of a girl with acne

The Amzeeq (minocycline; Foamix) topical foam 4% has received FDA approval for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients older than nine years.

Minocycline is a tetracycline-class drug, which has effectively been used in acne treatment for decades, but was hitherto available only as oral or systemic formulations. It will be available as a foam in a 30-gram aerosol container, from January 2020. It’s the first FDA-approved topical minocycline treatment for acne vulgaris.  

Amzeeq was well-tolerated during trials; improvements were noticed with no serious adverse effects other than headaches.             

Read the article click here

Back to Blog Page

Success Stories
Real Patients. Real Results.